Skip to search formSkip to main contentSkip to account menu

pentagamavunon-0

Known as: PGV-0 compound 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Introduction: Some analgesic drugs may have adverse effects on bone remodelling and, thus, on orthodontic tooth movement rate… 
2017
2017
ABSTRACT Objectives: This experiment aims to investigate the apoptosis effect of curcumin and its analogs pentagamavunon-0 (PGV-0… 
2016
2016
A salt compound of a curcumin analogue, potassium pentagamavunon-0 (K PGV-0) has been synthesized to improve solubility of… 
2016
2016
Abstract: Transdermal delivery system is one of the delivery system for Pentagamavunon-0 (PGV-0) to  avoid the high intensity of… 
2008
2008
PGV-0 merupakan senyawa modifikasi kurkumin yang memiliki aktivitas anti inflamasi dan memiliki sifat praktis tidak larut dalam… 
2006
2006
Breast cancer is the most common cancer occurring in women. Pentagamavunon-0 (2,5-bis-(4’-hidroxy-3’-methoksy)-benzilidine… 
2005
2005
PGV-0 is a curcumin derivate, a synthetic compound which may be a candidate of a new drug. This substance has a potent… 
2005
2005
The compound 2,5-bis-(4’-hydroxy-3’-methoxybenzilidin) cyclopentanone or Pentagamavunon-0 (PGV-0) as the new anti-inflamatory… 
2005
2005
Pentagamavunon-0 (PGV-0) or 2,5-bis-(4-hydroxy-3-methoxy benzyilidin) cyclopentanon is a synthetic compound which has been proved…